Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes
From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively treated with postoperative pelvic radiation. By study design, all patients underwent staging laparotomy with pelvic and paraaortic lymphadenecto...
Uložené v:
| Vydané v: | Gynecologic oncology Ročník 37; číslo 1; s. 51 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.04.1990
|
| Predmet: | |
| ISSN: | 0090-8258 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively treated with postoperative pelvic radiation. By study design, all patients underwent staging laparotomy with pelvic and paraaortic lymphadenectomy. All patients had either grade 1 or 2 adenocarcinoma and greater than 50% myometrial invasion or grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion. The estimated 5-year survival for all 45 patients was 77% and the 5-year disease-free interval was 82%. Regional control was achieved in 89% of all patients, with 4% recurring at distant sites. When patients were stratified according to surgical-pathologic findings, 33 patients with disease confined to the uterus or uterus and pelvic nodes (surgical stage I) had estimated 5-year survival and disease-free interval of 88%. Of these 33 patients, 10 with grade 1 or 2 adenocarcinoma and deep myometrial invasion had 5-year disease-free intervals of 100%, while 23 patients with grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion had disease-free intervals of 79 and 91%, respectively. From these results, it was concluded that patients with high-risk attributes demonstrated to have disease confined to the uterus or uterus and pelvic nodes can achieve excellent survival following surgical staging and postoperative pelvic radiation. |
|---|---|
| AbstractList | From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively treated with postoperative pelvic radiation. By study design, all patients underwent staging laparotomy with pelvic and paraaortic lymphadenectomy. All patients had either grade 1 or 2 adenocarcinoma and greater than 50% myometrial invasion or grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion. The estimated 5-year survival for all 45 patients was 77% and the 5-year disease-free interval was 82%. Regional control was achieved in 89% of all patients, with 4% recurring at distant sites. When patients were stratified according to surgical-pathologic findings, 33 patients with disease confined to the uterus or uterus and pelvic nodes (surgical stage I) had estimated 5-year survival and disease-free interval of 88%. Of these 33 patients, 10 with grade 1 or 2 adenocarcinoma and deep myometrial invasion had 5-year disease-free intervals of 100%, while 23 patients with grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion had disease-free intervals of 79 and 91%, respectively. From these results, it was concluded that patients with high-risk attributes demonstrated to have disease confined to the uterus or uterus and pelvic nodes can achieve excellent survival following surgical staging and postoperative pelvic radiation. From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively treated with postoperative pelvic radiation. By study design, all patients underwent staging laparotomy with pelvic and paraaortic lymphadenectomy. All patients had either grade 1 or 2 adenocarcinoma and greater than 50% myometrial invasion or grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion. The estimated 5-year survival for all 45 patients was 77% and the 5-year disease-free interval was 82%. Regional control was achieved in 89% of all patients, with 4% recurring at distant sites. When patients were stratified according to surgical-pathologic findings, 33 patients with disease confined to the uterus or uterus and pelvic nodes (surgical stage I) had estimated 5-year survival and disease-free interval of 88%. Of these 33 patients, 10 with grade 1 or 2 adenocarcinoma and deep myometrial invasion had 5-year disease-free intervals of 100%, while 23 patients with grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion had disease-free intervals of 79 and 91%, respectively. From these results, it was concluded that patients with high-risk attributes demonstrated to have disease confined to the uterus or uterus and pelvic nodes can achieve excellent survival following surgical staging and postoperative pelvic radiation.From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively treated with postoperative pelvic radiation. By study design, all patients underwent staging laparotomy with pelvic and paraaortic lymphadenectomy. All patients had either grade 1 or 2 adenocarcinoma and greater than 50% myometrial invasion or grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion. The estimated 5-year survival for all 45 patients was 77% and the 5-year disease-free interval was 82%. Regional control was achieved in 89% of all patients, with 4% recurring at distant sites. When patients were stratified according to surgical-pathologic findings, 33 patients with disease confined to the uterus or uterus and pelvic nodes (surgical stage I) had estimated 5-year survival and disease-free interval of 88%. Of these 33 patients, 10 with grade 1 or 2 adenocarcinoma and deep myometrial invasion had 5-year disease-free intervals of 100%, while 23 patients with grade 3 adenocarcinoma with less than or greater than 50% myometrial invasion had disease-free intervals of 79 and 91%, respectively. From these results, it was concluded that patients with high-risk attributes demonstrated to have disease confined to the uterus or uterus and pelvic nodes can achieve excellent survival following surgical staging and postoperative pelvic radiation. |
| Author | Caglar, H Marchetti, D L Driscoll, D L Hreshchyshyn, M M |
| Author_xml | – sequence: 1 givenname: D L surname: Marchetti fullname: Marchetti, D L organization: Department of Gynecology and Obstetrics, School of Medicine, State University of New York, Buffalo – sequence: 2 givenname: H surname: Caglar fullname: Caglar, H – sequence: 3 givenname: D L surname: Driscoll fullname: Driscoll, D L – sequence: 4 givenname: M M surname: Hreshchyshyn fullname: Hreshchyshyn, M M |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2323613$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kM1KAzEYRbOo1Lb6BgpZiS5G89OZJEsp_hQKdtH98M3kaxudSWqSUXx7CxZXF8493MWdkpEPHgm54uyeM149MGZYoUWpbw27M0wyVagRmfzjczJN6Z2xY8PFmIyFFLLickLWa-y-XEsjWAfZBU-dpynDDumSorehxxwddBQs-tBCbJ0PPdBvl_d073b7Irr0QSEfrWbImC7I2Ra6hJennJHN89Nm8Vqs3l6Wi8dV0UqtclEBb8CUcxDGbMFUc6wAQHPTogBkyjZWlFYqzecNcqWMxnLLJBouuJYgZuTmb_YQw-eAKde9Sy12HXgMQ6qVUZwxoY7i9Ukcmh5tfYiuh_hTnx4Qvw66Xlk |
| CitedBy_id | crossref_primary_10_1046_j_1525_1438_1999_99038_x crossref_primary_10_1002_1097_0142_19910601_67_11_2872__AID_CNCR2820671128_3_0_CO_2_8 crossref_primary_10_1016_0090_8258_91_90347_8 crossref_primary_10_1097_01_pgp_0000177123_78932_1d crossref_primary_10_1016_S0360_3016_02_02947_4 crossref_primary_10_1016_S0090_8258_03_00199_9 crossref_primary_10_1177_030089169808400111 crossref_primary_10_1016_S0889_8588_05_70160_X crossref_primary_10_1053_ctrv_2000_0195 crossref_primary_10_1016_S1053_4296_00_80016_8 crossref_primary_10_1006_gyno_1998_5098 crossref_primary_10_1016_S0002_9378_97_70601_X crossref_primary_10_1111_j_1479_828X_1994_tb01268_x crossref_primary_10_1016_0167_8140_93_90057_F |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/0090-8258(90)90307-7 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 2323613 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ADBBV ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CGR COF CS3 CUY CVF DM4 DU5 EBS ECM EFBJH EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LG5 M29 M41 MO0 N9A NPM O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- 7X8 AAYWO AGQPQ ~HD |
| ID | FETCH-LOGICAL-c387t-6a1ba954a299fa964e6aaa819ce2ae07dbd25d37814be17798e5f03e912183a2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 18 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=0090825890903077&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0090-8258 |
| IngestDate | Sun Sep 28 06:00:40 EDT 2025 Wed Feb 19 02:33:09 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c387t-6a1ba954a299fa964e6aaa819ce2ae07dbd25d37814be17798e5f03e912183a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 2323613 |
| PQID | 79710027 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_79710027 pubmed_primary_2323613 |
| PublicationCentury | 1900 |
| PublicationDate | 1990-04-01 |
| PublicationDateYYYYMMDD | 1990-04-01 |
| PublicationDate_xml | – month: 04 year: 1990 text: 1990-04-01 day: 01 |
| PublicationDecade | 1990 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Gynecologic oncology |
| PublicationTitleAlternate | Gynecol Oncol |
| PublicationYear | 1990 |
| SSID | ssj0003012 |
| Score | 1.4305409 |
| Snippet | From 1977 to 1987, 45 patients with FIGO stage I endometrial adenocarcinoma with high-risk attributes and disease confined to the pelvis were prospectively... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 51 |
| SubjectTerms | Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - radiotherapy Adult Aged Combined Modality Therapy Female Humans Middle Aged Neoplasm Staging Prospective Studies Recurrence Survival Rate Uterine Neoplasms - mortality Uterine Neoplasms - pathology Uterine Neoplasms - radiotherapy |
| Title | Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/2323613 https://www.proquest.com/docview/79710027 |
| Volume | 37 |
| WOSCitedRecordID | wos0090825890903077&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED4VihAL74ry9MAAg9UmceJYQkIIUcHQKkOHbpGdXFAlmpQ28Ps55wETYmDJEMmSdbnHF5_v-wCuKWQElWH6yTGJ4UK5CTdeKLjRIvN9g5QTRSU2ISeTcDZTUQfu2lkYe62yzYlVok6LxJ6RD6SyPDSuvF--c6sZZXurjYDGBnQ9AjI2LOXshyucXLfmCq-Gpf2wHZxzgsH3uxs1vFUVUaL8HWJWpWa0979N7sNuAzHZQ-0TB9DB_BC2x00T_QiiCN8oP7CVpSWw34XNc0Yg8RXZC8M8LRZYaXkwTTmJSt2KlhULzeyRLbP0xtzeR2e6rMWycH0M09HT9PGZN8IKPPFCWfJAO0YrX2iqRZlWgcBAa03YwKqD4VCmJnX91LNsWAYdKVWIfjb0UDkWUGm3B5t5keMJsCxwUuWgZ9BNhIvKJJk2UoYplT2jM7cPV62hYvJb24zQORYf67g1VR96ta3jZU2vERPG8whknP659Ax2HCqm9T2ac-hmFLB4AVvJZzlfry4rb6DnJBp_AW5TvyQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pelvic+radiation+in+stage+I+endometrial+adenocarcinoma+with+high-risk+attributes&rft.jtitle=Gynecologic+oncology&rft.au=Marchetti%2C+D+L&rft.au=Caglar%2C+H&rft.au=Driscoll%2C+D+L&rft.au=Hreshchyshyn%2C+M+M&rft.date=1990-04-01&rft.issn=0090-8258&rft.volume=37&rft.issue=1&rft.spage=51&rft_id=info:doi/10.1016%2F0090-8258%2890%2990307-7&rft_id=info%3Apmid%2F2323613&rft_id=info%3Apmid%2F2323613&rft.externalDocID=2323613 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon |